Bal Pharma Share Price
87.73+0.02 (+0.02%)
-1.87% past 1 Year
Bal Pharma Limited is a leading Indian Pharmaceutical Company specializing in Prescription Drugs Branded Formulations APIs Generic & OTC products Intravenous Infusions and Bulk Drugs. It has a rich experience
Corporate filings & documents
Announcements
In Continuation of Previous intimation hereby informing 17th September 2026 fixed as Record date for payment of final dividend and communication to shareholders regarding TDS on dividend payment
1 week agoIn Continuation of Previous intimation hereby informing 17th September 2026 fixed as Record date for payment of final dividend and communication to shareholders regarding TDS on dividend payment
1 week agoBal Pharma Limited Annual Report 2026
1 week agoBal Pharma Limited Annual Report 2026
1 week ago39th AGM of the Company Scheduled on 24th September 2026. Notice copy enclosed
1 week ago39th AGM of the Company Scheduled on 24th September 2026. Notice copy enclosed
1 week agoThis is to inform that 39th AGM of Bal Pharma Limited Scheduled to be held on Thursday 24th September 2026 at 11.00 AM through VC Mode.
1 week agoThis is to inform that 39th AGM of Bal Pharma Limited Scheduled to be held on Thursday 24th September 2026 at 11.00 AM through VC Mode.
1 week agoThis is in Continuation of Company earlier intimation made in connection with allotment of warrants hereby clarify that utilization of net proceeds or tenure of warrants is 18 month from the date of allotment subject to requisite in- principle approval of the stock exchanges.
1 week agoThis is in Continuation of Company earlier intimation made in connection with allotment of warrants hereby clarify that utilization of net proceeds or tenure of warrants is 18 month from the date of allotment subject to requisite in- principle approval of the stock exchanges.
1 week agoIn Continuation of Outcome of Board meeting dated August 12 2026 Published Unaudited Financial result for the quarter ended 30th June 2026 and IEPF Notice in Financial express and Sanjevani Newspapers on 13th August 2026
3 weeks agoIn Continuation of Outcome of Board meeting dated August 12 2026 Published Unaudited Financial result for the quarter ended 30th June 2026 and IEPF Notice in Financial express and Sanjevani Newspapers on 13th August 2026
3 weeks agoEnclosed Financial Result for the First quarter ended 30th June 2026 together with Limited Review Report as submitted by Statutory auditor
3 weeks agoEnclosed Financial Result for the First quarter ended 30th June 2026 together with Limited Review Report as submitted by Statutory auditor
3 weeks agoBoard of directors of the Company met on Wednesday August 12 2026 inter alia transacted the following business.1. Considered and approved the unaudited Financial Results (Standalone and Consolidated) of the Company quarter ended on 30th June 20262. Approved the change in designation of Mr. Ravindra Kumar Kothari (DIN: 03418320) from Non-Executive Director to Whole-Time Director 3. Approved the change in designation of Mr. Virupakshaya Himesh (DIN: 08554422) from Whole-Time Director to Non-Executive Director with effect from October 1 20264. Approved the proposal to make investment in the proposed Joint Venture entity to be incorporated in the Republic of the Philippines5 approved the allotment of 10 00 000 (Ten Lakhs) Warrants to Mr. Shailesh Siroya Promoter of the Company on preferential basis
3 weeks agoBoard of directors of the Company met on Wednesday August 12 2026 inter alia transacted the following business.1. Considered and approved the unaudited Financial Results (Standalone and Consolidated) of the Company quarter ended on 30th June 20262. Approved the change in designation of Mr. Ravindra Kumar Kothari (DIN: 03418320) from Non-Executive Director to Whole-Time Director 3. Approved the change in designation of Mr. Virupakshaya Himesh (DIN: 08554422) from Whole-Time Director to Non-Executive Director with effect from October 1 20264. Approved the proposal to make investment in the proposed Joint Venture entity to be incorporated in the Republic of the Philippines5 approved the allotment of 10 00 000 (Ten Lakhs) Warrants to Mr. Shailesh Siroya Promoter of the Company on preferential basis
3 weeks agoScrutinizers Report Pertaining to Postal Ballot Notice dated July 09 2026 read with its Corrigendum dated July 23rd 2026.
3 weeks agoScrutinizers Report Pertaining to Postal Ballot Notice dated July 09 2026 read with its Corrigendum dated July 23rd 2026.
3 weeks agoOutcome : Result of Postal Ballot Notice dated July 09 2026 read with its Corrigendum dated July 23 2026
3 weeks agoOutcome : Result of Postal Ballot Notice dated July 09 2026 read with its Corrigendum dated July 23 2026
3 weeks agoBal Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 inter alia to consider and approve Pursuant to Regulation 29 and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you that a meeting of the Board of Directors of Bal Pharma Limited is scheduled to be held on Wednesday August 12 2026 inter alia to consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30 2026 (Q1/2026-27) and such other matters as may be considered necessary with the permission of the Chair.
1 month agoBal Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 inter alia to consider and approve Pursuant to Regulation 29 and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you that a meeting of the Board of Directors of Bal Pharma Limited is scheduled to be held on Wednesday August 12 2026 inter alia to consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30 2026 (Q1/2026-27) and such other matters as may be considered necessary with the permission of the Chair.
1 month agoCompany Providing opportunity to shareholders to Submit their Comments on Corrigendum to the Postal ballot notice
1 month agoCompany Providing opportunity to shareholders to Submit their Comments on Corrigendum to the Postal ballot notice
1 month agoIn Continuation of Postal Ballot Notice dated 09th July 2026 Submitting Corrigendum as integral part to the Said Notice.
1 month agoIn Continuation of Postal Ballot Notice dated 09th July 2026 Submitting Corrigendum as integral part to the Said Notice.
1 month agoCertificate under Regulation 74(5) of SEBI (DP) Regulations for the quarter ended 30.06.2026
1 month agoCertificate under Regulation 74(5) of SEBI (DP) Regulations for the quarter ended 30.06.2026
1 month agoPostal Ballot Notice for consider the issue of 1000000 Warrants to Mr. Shailesh Siroya promoter of the Company on preferential basis
1 month agoPostal Ballot Notice for consider the issue of 1000000 Warrants to Mr. Shailesh Siroya promoter of the Company on preferential basis
1 month agoThis is with reference to our earlier intimation dated 27th May 2026 regarding appointment of Mr. Shreepada ML as company secretary and compliance officer of the company pursuant to the approval of the board of directors at its meeting held on 27th may 2026 we hereby confirm that Mr. Shreepada ML (M No A66681) has taken charge and commenced his duties as the company Secretary and compliance officer (KMP) of the Company with effect from 23rd June 2026.
2 months agoThis is with reference to our earlier intimation dated 27th May 2026 regarding appointment of Mr. Shreepada ML as company secretary and compliance officer of the company pursuant to the approval of the board of directors at its meeting held on 27th may 2026 we hereby confirm that Mr. Shreepada ML (M No A66681) has taken charge and commenced his duties as the company Secretary and compliance officer (KMP) of the Company with effect from 23rd June 2026.
2 months agoTrading window closure for the quarter ended 30.06.2026.
2 months agoTrading window closure for the quarter ended 30.06.2026.
2 months agoWe are submitting the newspaper advertisements of the Audited financial results ( standalone & Consolidated ) for the quarter and financial year ended 31.03.2026 announced by the Company on 27.05.2026 and published in Financial express (English ) and Sanjayvani ( Kannada) on 29.05.2026.
3 months agoWe are submitting the newspaper advertisements of the Audited financial results ( standalone & Consolidated ) for the quarter and financial year ended 31.03.2026 announced by the Company on 27.05.2026 and published in Financial express (English ) and Sanjayvani ( Kannada) on 29.05.2026.
3 months agoFiling of Statement of deviation & variation is not applicable to the Company for the quarter ended 31.03.2026.
3 months agoFiling of Statement of deviation & variation is not applicable to the Company for the quarter ended 31.03.2026.
3 months agoAudited financial results of the company for the quarter and financial year ended 31.03.2026.
3 months agoAudited financial results of the company for the quarter and financial year ended 31.03.2026.
3 months agoBoard of Directors of the Company has met today and transacted following business 1. Approved audited financial results of the Company for the quarter and financial year ended 31.03.2026.2.Recommend dividend of Rs1.20 per equity share of Rs.10 each i.e 12%3.Appointed Cost Auditors and Internal auditors for the financial year 2026.27.4. Approved grant of 5 00 000 stock options to the employees of the company under "Bal Pharma Ltd-Employee Stock Option Plan-2025"5.Approved preferential issue of 10 00 000 warrants to the promoters.6. Take shareholders approval for preferential issue through postal ballot.7.Approved appointment of Mr.Shreepada M.L (M # A66681) as Company Secretary and compliance officer of the company.
3 months agoIn addition to the agenda items mentioned in our board meeting notice dated 18.05.2025 the following agenda item will also be considered at the meeting scheduled on 27.05.2026.1. To consider and approve proposal for fund raising through preferential issue of warrants to promoters.All other details and agenda items will remain unchanged.Please take this intimation on record.
3 months agoIn addition to the agenda items mentioned in our board meeting notice dated 18.05.2025 the following agenda item will also be considered at the meeting scheduled on 27.05.2026.1. To consider and approve proposal for fund raising through preferential issue of warrants to promoters.All other details and agenda items will remain unchanged.Please take this intimation on record.
3 months agoAnnual Secretarial Compliance Report for the financial year ended 31.03.2026.
3 months agoBal Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2026 inter alia to consider and approve 1. Audited financial results of the Company for the quarter and financial year ended 31.03.2026.2. Audited standalone and consolidated accounts of the Company together with auditors report for the F.Y ended 31.03.2026.3. To recommend dividend if any for the F.Y 2025.26.4. To grant stock options to the employees of the Company under "Bal Pharma Ltd- Employee Stock Option Plan 2025"
3 months agoBal Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2026 inter alia to consider and approve 1. Audited financial results of the Company for the quarter and financial year ended 31.03.2026.2. Audited standalone and consolidated accounts of the Company together with auditors report for the F.Y ended 31.03.2026.3. To recommend dividend if any for the F.Y 2025.26.4. To grant stock options to the employees of the Company under "Bal Pharma Ltd- Employee Stock Option Plan 2025"
3 months agoIntimation on resignation of Company Secretary & Compliance officer.
3 months agoIntimation on resignation of Company Secretary & Compliance officer.
3 months agoCertificate under Regulation 74(5) of SEBI(DP) Regulations for the quarter ended 31.03.2026.
5 months agoCertificate under Regulation 74(5) of SEBI(DP) Regulations for the quarter ended 31.03.2026.
5 months agoAnnual reports
Concalls & investor presentations
Aug 2022
ConcallPresentation
Corporate Actions
Date
Type
Details
2026-09-17
Dividend
1.2
2025-09-18
Dividend
1.2
2024-09-17
Dividend
1.2
2023-09-18
Dividend
1.0
2022-09-13
Dividend
1.0
2021-09-16
Dividend
1.0
2019-09-17
Dividend
1.0
2018-09-14
Dividend
1.0
2017-09-14
Dividend
1.0
2016-09-15
Dividend
1.0
2015-09-15
Dividend
1.0
2014-09-12
Dividend
1.0
2013-09-12
Dividend
0.75
Company details
Registered office
#21&22, Bommasandra Industrial Area Anekal Taluk Bengaluru Karnataka PIN: 560099 Tel No: 080 41570811 / 13 / 19 Fax No: 080 41570820 / 22354057 Email: [email protected] Internet: www.balpharma.com
Registrars
C-101, 1st Floor, 247 Park, Lal Bahadur Shastri Marg, Vikhroli (West), Mumbai 400 083(Old Address:6-10, Haji Moosa Patrawala Indl. Est 20, Dr.E.Moses Road, Mahalaxmi, Mumbai Maharashtra) C-101, 1st Floor 247 Park, Lal Bahadur Shastri Marg Vikhroli West PIN: Tel No: 91 22 6656 8484 Fax No: 91 22 6656 8494 Email: [email protected] Internet: https://in.mpms.mufg.com/
Management
Shreepada ML, Company Secretary & Compliance Officer
Shailesh Siroya, Chairman & Managing Director
Shailesh Siroya, Chairman & Managing Director
Ravindra Kumar Kothari, Whole Time Director
Jatish Sheth, Non Executive Independent Director
Nicola Neeladri, Non Executive Independent Director
Bheekamchand Mukesh, Non Executive Independent Director
Details
BSE 524824
NSE BALPHARMA
ISIN INE083D01012